Bracco Diagnostics Inc. Branded Max 3™, a Rapid Exchange and Syringeless Injector, received FDA 510(k) clearance adding evolving innovation in Magnetic Resonance Imaging (MRI) and its product portfolio
Press Releases
Bracco Group  
December 2, 2024

Bracco Diagnostics Inc. Branded Max 3™, a Rapid Exchange and Syringeless Injector, received FDA 510(k) clearance adding evolving innovation in Magnetic Resonance Imaging (MRI) and its product portfolio

With this clearance, Bracco sets a new standard for patient care in Magnetic Resonance Imaging (MRI)

avatar profile Olean Times Herald

Olean Times Herald


Local & Social